Stock Fundamentals

Company Information

Company Name
Milestone Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: CA59935V1076
CIK: 0001408443
CUSIP: 59935V107
Currency: USD
Full Time Employees: 38
Phone: 514 336 0444
Fiscal Year End: December
IPO Date: May 09, 2019
Description:

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Address:

1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6

Directors & Officers

Name Title Year Born
Mr. Joseph G. Oliveto M.B.A. CEO, President & Executive Director 1968
Mr. Amit Hasija CFO & Executive VP of Corporate Development 1973
Dr. David B. Bharucha FACC, M.D., Ph.D. Chief Medical Officer 1962
Dr. Philippe Douville M.B.A., Ph.D. Founder, Strategic Advisor & Member of Scientific Advisory Board 1962
Mr. Jeffrey Nelson Chief Operating Officer 1981
Mr. David Sandoval General Counsel & Chief Compliance Officer 1978
Mr. Roshan Girglani Vice President of Marketing NA
Mr. Jeff Moore Vice President of Sales NA
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. Chief Medical Advisor & Member of the Scientific Advisory Board 1956
Dr. Guy Rousseau SVP of Regulatory Affairs and Quality Management NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 16, 2026 Joseph Oliveto N/A Sale 36.50K $2.26 $82.49K
Jan 26, 2026 David Bharucha N/A Sale 12.25K $1.93 $23.63K
Jan 26, 2026 Jeffrey Edward Nelson N/A Sale 12.25K $1.93 $23.63K
Jan 26, 2026 Joseph Oliveto N/A Sale 34.52K $1.93 $66.63K
Jan 26, 2026 Lorenz Muller N/A Sale 11.18K $1.93 $21.58K
Jan 08, 2026 Joseph Oliveto N/A Sale 43.00K $2.25 $96.75K
Jan 07, 2026 Joseph Oliveto N/A Sale 500.00 $2.25 $1.13K
Dec 15, 2025 David Bharucha N/A Sale 58.01K $2.32 $134.58K
Dec 15, 2025 Jeffrey Edward Nelson N/A Sale 58.01K $2.32 $134.58K
Dec 15, 2025 Joseph Oliveto N/A Sale 133.05K $2.32 $308.69K
Dec 15, 2025 Lorenz Muller N/A Sale 53.57K $2.32 $124.27K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RTW INVESTMENTS, LLC 6.33M Mar 31, 2026 5.37% $0.08 152.62%
Propel Bio Management LLC 4.12M Dec 31, 2025 3.50% $7.10 -19.64%
Two Sigma Investments LLC 2.32M Mar 31, 2026 1.97% $0.00 53.00%
The Goldman Sachs Group Inc 2.00M Mar 31, 2026 1.70% $0.00 0.00%
Marshall Wace Asset Management Ltd 1.94M Mar 31, 2026 1.65% $0.00 17.37%
Millennium Management LLC 1.54M Mar 31, 2026 1.31% $0.00 283.55%
Simplify Asset Management Inc. 1.51M Mar 31, 2026 1.28% $0.03 0.00%
Point72 Asset Management, L.P. 1.09M Mar 31, 2026 0.92% $0.00 125.08%
Balyasny Asset Management LLC 851.33K Mar 31, 2026 0.72% $0.00 0.00%
Lion Point Capital, LP 820.00K Mar 31, 2026 0.70% $5.83 8.61%
The Toronto-Dominion Bank 750.00K Mar 31, 2026 0.64% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 724.14K Mar 31, 2026 0.61% $0.00 -7.38%
Boxer Capital Management, LLC 666.67K Mar 31, 2026 0.57% $0.10 0.00%
Two Sigma Advisers, LLC 619.59K Dec 31, 2025 0.53% $0.00 164.74%
Susquehanna International Group, LLP 519.05K Mar 31, 2026 0.44% $0.00 -19.32%
UBS Group AG 494.91K Mar 31, 2026 0.42% $0.00 0.62%
Squarepoint Ops LLC 336.83K Mar 31, 2026 0.29% $0.00 35.08%
Seven Fleet Capital Management LP 333.33K Mar 31, 2026 0.28% $0.13 0.00%
Aptus Capital Advisors, LLC 280.25K Mar 31, 2026 0.24% $0.00 6.48%
GUARDIAN WEALTH ADVISORS, LLC / NC 280.25K Mar 31, 2026 0.24% $0.02 6.48%

Shares Statistics

Shares Outstanding: 124.50M
Shares Float: 14.07M
% Insiders: 247.70%
% Institutions: 2,499.30%
Short % Float: 6.58%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Simplify Propel Opportunities ETF 3.35M 2.80% ▲ 0.00% Apr 30, 2026
2 Invesco NASDAQ Future Gen 200 ETF 42.80K 0.04% ▲ 0.59% Apr 30, 2026
3 Fidelity Nasdaq Composite Index 40.79K 0.03% ▼ 44.90% Mar 31, 2026
4 State Street® SPDR® S&P® Intl Sm Cp ETF 22.68K 0.02% ▲ 0.00% Apr 30, 2026
5 Blackstone Alternative Multi-Strategy I 2.50K 0.00% ▲ 0.00% Sep 30, 2025

Valuation Metrics

Enterprise Value: $45.56M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $164.34M
EBITDA: $-62.03M
Book Value: $0.34
Earnings/Share: $-0.64
Profit Margin: 0.00%
Operating Margin: -1,116.24%
ROA (TTM): -41.09%
ROE (TTM): -229.65%
Revenue (TTM): $1.55M
Revenue/Share (TTM): $0.02
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.01x 1.38x 0.63x -16.28x -0.93x
2024-12-31 9.10x 4.10x 0.83x -11.76x -1.43x
2023-12-31 10.11x 3.00x 0.78x -23.92x -0.88x
2022-12-31 11.70x 0.01x 0.11x -47.56x -0.01x
2021-12-31 17.55x 0.00x 0.06x -195.79x -0.01x
2020-12-31 24.14x 0.00x 0.05x -69.85x 0.00x
2019-12-31 14.71x 0.00x 0.07x -22.30x -0.01x
2018-12-31 19.42x 0.00x 1.63x N/A 0.00x
2017-12-31 17.17x 0.00x 2.20x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MIST.US!